CIPLA LTD. - 500087 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 30(3) and other applicable regulations of SEBI listing regulations 2015, we would like to inform you that registrar and transfer agent of company M/S KFin Technologies limited has received intimation for loss of share certificates and request for issuance of duplicate share certificates. CIPLA LTD. - 500087 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) and other applicable regulations of SEBI listing regulations 2015, we would like to inform you that Registrar and Transfer Agent of Company M/S. KFin Technologies Limited has received intimation for loss of shares certificate and request for issuance of duplicate share certificates
Why Cipla's potential sale is getting delayed
In recent months, Cipla has garnered considerable attention due to a series of major developments. It all commenced when Blackstone made a bold proposal to acquire a 33.46 per cent stake in the Hamied family's business for $3.8 billion
Cipla shares trade down after FDA inspection at US facility
Cipla's manufacturing facility received the VIA classification from the USFDA, meaning it is in a minimally acceptable state of compliance with regards to good manufacturing practice CIPLA LTD. - 500087 - Update On USFDA Inspection At Invagen Manufacturing Facility In Central Islip, Long Island, NY, USA
Updates on USFDA inspection at InvaGen manufacturing facility in central Islip, long insland, NY, USA CIPLA LTD. - 500087 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issuance of Letter of Confirmation CIPLA LTD. - 500087 - Earnings Conference Call
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are enclosing herewith the schedule of Earnings Conference call to be held on 27th October, 2023. CIPLA LTD. - 500087 - Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September 2023.
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of Listing Regulations, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday, 27th October 2023 inter-alia to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2023. In terms of the Company's Code of Conduct for Prevention of Insider Trading, the 'Trading Window' for dealing in the securities of the Company is closed from Sunday, 1st October 2023 till Sunday, 29th October 2023 (both days inclusive) for the purpose of financial results. CIPLA LTD. - 500087 - Update On Sale Of Stake Held In Saba Investment Limited, UAE
Update on sale of stake held in Saba Investment Limited, UAE CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
In compliance with the provisions of Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company on 29th September, 2023 has allotted 7,951 fully paid up equity shares pursuant to exercise of ESOP/ ESARs. Consequently, the issued, subscribed, paid-up share capital of the Company increased to 1,61,46,50,858 comprising of 80,73,25,429 equity shares.